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ABSTRACT 
Objective: We aimed to compare the diagnostic utility of T1-weighted (T1w) and STIR 
MRI sequences in early spondyloarthritis (SpA) using a standardized approach to the 
evaluation of sacroiliac joints (SIJ) and to test whether systematic calibration of read-
ers directed at recognition of abnormalities on T1w MRI would enhance diagnostic 
utility.  
Methods: Six readers independently assessed T1w and STIR MRI scans of the SIJ 
from 187 subjects: 75 AS and 27 preradiographic IBP patients; 26 mechanical back 
pain and 59 healthy volunteer controls aged ≤45 years. The exercise was repeated 6 
months later on a random selection of 30 AS patients and 34 controls after calibration 
directed at lesions visible on T1w MRI. Specific MRI lesions were recorded according 
to standardized definitions. In addition to deciding on the presence/absence of SpA 
readers were asked which MRI sequence and which type of lesion was the primary 
basis for their diagnostic conclusion.  
Results: Structural lesions were detected in 98% of AS and in 64% of IBP patients. A 
diagnosis of SpA was based on T1w or combined T1w/STIR sequences in 82% of AS 
and 41% of IBP patients. Calibration enhanced diagnostic utility of MRI in the majority 
of readers, especially those considered less experienced; mean (of 6 readers) pre-
calibration likelihood ratio (LR) (+/-) was 14.5/0.08 and post-calibration was 22.2/0.02.  
Conclusion: Recognition of structural lesions on T1w MRI contributes significantly to 
its diagnostic utility in early SpA. Rheumatologist training directed at detection of le-
sions visible on T1w MRI enhances diagnostic utility.  
Page 4 of 39
John Wiley & Sons, Inc.
Arthritis Care & Research
 5 
INTRODUCTION 
There is increasing acceptance that MRI has high diagnostic utility in early 
spondyloarthritis (SpA). Most prior studies on the diagnostic utility of MRI in early SpA 
patients (1-5) and a recent consensus-driven Assessment of SpondyloArthritis 
(ASAS) International Society proposal to define sacroiliitis by MRI (6) have focused 
only on the presence of bone marrow edema (BME) on short tau inversion recovery 
(STIR) sequences or on osteitis on the T1-weighted gadolinium augmented sequence 
as the principle diagnostic features. But an approach that is restricted to active 
sacroiliitis may ignore the potential contribution to diagnostic utility of early structural 
abnormalities characteristically observed on T1-weighted (T1w) sequences. 
Information on the occurrence and relative importance of structural changes in the SIJ 
observed on T1w MRI early in the disease course of SpA is, however, scarce. 
Furthermore, structural abnormalities such as erosions may be difficult to diagnose on 
MRI while sclerosis and marrow fat infiltration have an uncertain diagnostic 
significance. It is therefore unclear whether structural lesions occur sufficiently 
frequently in early SpA to warrant diagnostic scrutiny, to what degree their 
assessment contributes to the diagnostic utility of MRI in SpA, and whether diagnostic 
utility of individual readers can be improved by reader training to recognize 
abnormalities on T1w MRI.  
In this international multi-reader MRI standardization, calibration, and reading 
exercise of 187 patients with early SpA and age and sex matched controls, we 
analyzed the frequency of structural lesions of the SIJ in early SpA and assessed the 
contribution of T1w MRI to diagnostic utility in early SpA using a standardized 
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approach to the evaluation of SIJ that included the following: 1. Development of 
standardized definitions of structural lesions of the SIJ on T1w MRI by the Canada-
Denmark MRI Working Group; 2. Development of a reference SIJ MR image set by 
consensus amongst study investigators based on these definitions 
(www.arthritisdoctor.ca); 3. Calibration of readers using an online training module 
(www.arthritisdoctor.ca) followed by videoteleconferences; 4. Development of a 
customized online data entry module based on a standardized approach to recording 
abnormalities in the SIJ (www.arthritisdoctor.ca). We also conducted a second 
reading exercise to determine whether training of less experienced readers directed 
specifically at detection of structural abnormalities on T1w scans enhances overall 
diagnostic utility of MRI in early SpA.  
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PATIENTS AND METHODS 
Subjects 
6 readers (4 rheumatologists and 2 radiologists) from 3 international centers, 
blinded to patient and diagnosis, independently assessed T1w and STIR sequences 
of SIJ MRI scans from 187 subjects aged ≤45 years, who were recruited in 2 
rheumatologic university clinics specializing in SpA. 75 AS patients who met the 
modified New York classification criteria (7) and with a disease duration ≤10 years 
(mean age 31.1 years; mean symptom duration 6.1 years; 72% male, 59/71 (83%) 
HLA B27 positive); 27 patients with inflammatory back pain (IBP) and clinically 
diagnosed with pre-radiographic SpA with a mean symptom duration of 29 months 
(mean age 29 years; 67% male, 23/25 (92%) HLA B27 positive); 26 age and sex 
matched controls ≤45 years of age with non-specific back pain (NSBP) diagnosed on 
clinical grounds; 59 age and sex matched healthy controls ≤45 years of age defined 
by the Nordic questionnaire (8). Treatment with biologics within 6 months prior to the 
SIJ MRI was an exclusion criterion in the AS and IBP group. Pelvic radiographs of 
both SpA patient groups were independently assessed and categorized according to 
the modified New York criteria (7) by two readers at each site. The local Ethics 
Committees approved the study protocol, and written informed consent was obtained 
from all participants.  
MRI protocol 
Scans from both centres included coronal T1w Turbo spin-echo (T1SE) and 
STIR sequences angled parallel to the sacroiliac joint. The scan parameters for all 
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sequences were: 15-19 slices, 4 mm slice thickness, 0.4 mm interslice gap and field 
of view of 280-300 mm. For the T1w sequence, repetition time (TR) was 423-450 ms, 
echo time (TE) 12-13 ms, Echo Train Length (ETL) 3, Matrix 512 x 256 pixels. For the 
STIR sequence, the values were: TR 3700-4930 ms, inversion time (TI) 145-150 ms, 
TE 50-69 ms, ETL 7-9, Matrix 256-384 x 256 pixels. These are the usual sequences 
and scan parameters for routine MRI evaluation of patients with SpA in the involved 
institutions.  
Standardized assessment of MR images 
These are the steps that were followed in chronological order prior to the for-
mal evaluation of any of the MRI scans:  
1. Standardized definitions of MR lesions: We adopted standardized definitions 
of active inflammatory changes on STIR images and structural lesions on T1w 
sequences of the SIJ developed by the Canada-Denmark MRI Working Group (9). 
BME is defined as an increase in bone marrow signal in the SIJ on STIR images; the 
center of the sacrum at the same craniocaudal level is used as the primary reference 
for normal bone marrow signal (10). We defined joint erosions as full-thickness loss of 
dark appearance of either iliac or sacral cortical bone of the SIJ and loss of normal 
bright appearance of adjacent bone marrow on T1w images; adjacent bone marrow 
demonstrates decreased signal intensity on T1w images as compared to normal iliac 
marrow (for iliac erosions) or normal sacral marrow (for sacral erosions) on the same 
slice at the same craniocaudal level. We defined marrow fat infiltration as focal 
increased signal in bone marrow on T1w images. We defined ankylosis as bright 
signal on T1w images extending across the SIJ. Figure 1 illustrates joint erosions and 
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marrow fat infiltration on a T1w image of the anterior part of the SIJ with minimal BME 
on the corresponding STIR sequence slice.  
2. Reference SIJ MR image set: We developed a reference SIJ MR image set 
by consensus amongst study investigators based on the definitions for these 4 types 
of lesions (www.arthritisdoctor.ca). Four videoteleconference sessions involving the 3 
university centers focused on the application of the standardized definitions of SIJ 
MRI lesions and served to calibrate the reader team by conducting 2 test reading 
exercises on SIJ scans displaying acute and structural lesions.  
3. Standardized assessment of MR lesions of the SIJ: We standardized the 
approach to assessing MR images of the SIJ by adopting the methodology outlined in 
the online training module (9).  
4. Online data entry module: We developed a customized online data entry 
module for recording MRI findings based on a standardized approach to recording 
abnormalities in the SIJ. It has 2 sections. The first section contains 3 questions that 
address global assessment of each scan: 1. “This MRI scan confirms the presence of 
SpA (agree/disagree)”; 2. “Your conclusion is based on which MRI sequence (STIR, 
T1SE, both sequences)”; 3. “What is the primary MRI feature on which your diagnosis 
of SpA is based (bone marrow edema, bone erosion, fat replacement, ankylosis, not 
applicable as SpA is not present)”. The second section of the web-based data entry 
module consists of a detailed scoring section where the SIJ is represented as a 
schematic with 4 quadrants (upper and lower ilium, upper and lower sacrum). Each 
lesion, except for ankylosis, is recorded as being present/absent on a dichotomous 
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basis in each quadrant. Ankylosis is recorded in each half of the joint (upper and/or 
lower).  
Reading exercises 
We conducted two reading exercises. First, the scans of all 187 individuals 
were evaluated in random order on electronic work stations in the institution of each 
reader. The same reading exercise was repeated 6 months later on a random selec-
tion of 30 AS patients with a symptom duration ≤5 years and 34 controls (26 NSBP 
patients and 8 healthy volunteers) from the original study population. The mean age 
of the 30 AS patients was 28.6 years (standard deviation (SD) 5.8) with a mean 
symptom duration of 3.1 years (SD 1.6), 70% were male. They showed a mean Bath 
Ankylosing Spondylitis Disease Activity Index (BASDAI) (11) of 4.3 (SD 2.0) and a 
mean Bath Ankylosing Spondylitis Functional Index (BASFI) (12) of 2.8 (SD 2.7); the 
mean C-reactive protein (CRP; reference range ≤5 mg/l) was 14.9 mg/l (SD 27.2). 25 
of 28 AS patients tested for HLA B27 were positive (89%). 26 NSBP patients and 8 
healthy volunteers had a mean age of 33.8 years (SD 7.9) and 34.3 years (SD 5.8), 
respectively, with 58% and 88% being male, respectively. Two videoteleconference 
training sessions between the 2 readouts were directed at recognition of structural 
abnormalities on T1w images and served to refine a second reference MR image set 
developed by group consensus that focused on structural lesions. The aim of this 
second reading exercise was to determine whether training/calibration focused on 
structural lesions could improve diagnostic utility, particularly for the two least experi-
enced readers. 
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Statistical analysis 
The frequency of SpA patients and controls with specific MRI abnormalities, all 
3 structural lesions combined, a structural lesion in the absence of BME and vice 
versa, was analyzed descriptively according to single readers and mean (range) for 
all 6 readers. For both SpA groups, the contribution of T1w versus STIR sequence 
MRI and of BME versus structural lesions towards the diagnosis of SpA by MRI was 
also analyzed descriptively according to single readers, mean (range) for all readers, 
and stratified by reader specialty i.e. radiologist or rheumatologist.  
Diagnostic utility of MRI for SpA was determined by calculating sensitivity, 
specificity, positive (LR+) and negative likelihood ratios (LR-) for individual reader 
data, diagnoses recorded concordantly by all readers, and for diagnoses recorded 
concordantly by all rheumatologists and both radiologists. We compared diagnostic 
utility before and after training/calibration of readers to recognize structural lesions on 
T1w MRI. The 6-month post-calibration readout included a descriptive assessment of 
the relative contribution of T1w versus STIR sequence and of acute versus structural 
MRI lesions to the diagnosis of SpA which was compared with the pre-calibration 
readout.  
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RESULTS 
Descriptive analysis 
Frequency of structural lesions in both SpA and control groups: Erosions and 
fat replacement were recorded in 80.4% (56-95%) and 87.3% (85-89%), respectively, 
of the 75 AS patients by the 6 readers (Table 1). Radiologists recorded a higher 
frequency of erosions compared to rheumatologists (88.7% versus 76.3%, 
respectively). At least one of the 3 structural lesions was recorded in 98.2% (93-
100%) of AS patients while BME was recorded in 81.6% (72-89%). Structural lesions 
in the absence of BME were found in 18.2% of AS patients whereas BME without 
structural lesions was virtually absent (1.6%).  
At least one structural lesion was recorded in 63.6% (41-78%) of IBP patients 
by the 6 readers while BME was recorded in 69.1% (59-78%). MRI lesions were not 
recorded on either sequence in 17.9% (11-30%) of the 27 IBP patients. Erosions 
were recorded in 50% of IBP patients and radiologists observed erosions more 
frequently than rheumatologists in this patient group also (63% versus 43.5%, 
respectively), while BME was recorded more frequently by the rheumatologists 
(71.3% versus 64.8%, respectively). A structural lesion in the absence of BME and 
vice versa was observed with a comparable frequency of 13% and 18.5%, 
respectively.  
In both control groups, any structural lesion was observed in 27% of 
individuals. However, while BME was observed in 21.8% (12-46%) and 17.8% (7-
32%) of NSBP and healthy controls, respectively, erosions were recorded in 13.5% 
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(0-27%) and 11.9% (2-22%) of corresponding controls. BME with and without 
structural lesions were recorded in 10.9% and 10.9% in the NSBP patients and in 
8.5% and 9.3% of the healthy volunteers, respectively.  
Relative importance of T1w versus STIR sequence and BME versus structural 
lesions (Table 2): T1w images alone or together with STIR images were indicated as 
most important in concluding that the MRI was indicative of SpA in 97% of AS 
patients by the radiologists and in 74% by the rheumatologists. For diagnosing SpA 
by MRI in the IBP group, the T1w sequence, either alone or in combination with STIR, 
was still considered more important than the STIR by radiologists for 67% of patients 
whereas STIR alone was considered more important by rheumatologists for 70% of 
IBP patients. In regards to the relative importance of the 4 different MRI lesions, BME 
was considered most important in 26% of the AS patients by the radiologists and in 
68% by the rheumatologists, respectively; Erosions on T1w images were recognized 
as most important in 46% by the radiologists and in 10% by the rheumatologists. In 
contrast, BME was indicated as the most important lesion in 81% of IBP patients by 
the radiologists and in 90% by the rheumatologists, respectively. Erosions were 
considered most important in 11% and 4% of the IBP patients by radiologists and 
rheumatologists, respectively.  
Impact of calibration for T1w abnormalities on diagnostic utility of MRI 
Pre-calibration, the mean sensitivity and specificity of MRI for a diagnosis of 
SpA in 30 AS patients chosen randomly from the original cohort and 34 controls (26 
with NSBP and 8 Healthy) were 92% and 94%, respectively, while the mean LR+ and 
LR- were 14.5 and 0.08, respectively (Table 3). Post-calibration, the mean sensitivity 
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and specificity of MRI improved to 98% and 96%, respectively, while mean LR+ and 
LR- improved to 22.2 and 0.02, respectively. In the 4 experienced readers, sensitivity 
increased in 1 reader at the cost of a slight decrease in specificity. In one of the 2 less 
experienced readers, sensitivity markedly increased from 77% to 97% with a slight 
decrease in specificity (94% versus 100%); the second reader with limited experience 
improved both sensitivity (100% versus 93%) and specificity (97% versus 79%).  
Concordance for the diagnosis of SpA by any 2 readers was 100% for both the 
pre- and post-calibration readout. Agreement regarding the diagnosis of SpA amongst 
all 6 readers in the pre-calibration readout was 67% (20/30) and for the absence of 
SpA in the control group was 76% (26/34). Post-calibration agreement for the 
diagnosis of SpA amongst all 6 readers increased to 90% (27/30 AS patients) and for 
the absence of SpA in controls to 82% (28/34).  
Table 4 shows the contribution of T1w versus STIR towards the diagnosis of 
SpA. Pre-calibration, the T1w sequence, alone or in combination with the STIR 
sequence, was considered most important in 95% of AS patients by the radiologists 
and in 69% by the rheumatologists. Post-calibration, this did not change for 
radiologists but for rheumatologists the T1w sequence, alone or with STIR, was now 
considered most important in 85% of patients. This difference in approach to 
diagnostic ascertainment by rheumatologists was also reflected in the analysis of the 
type of MRI lesions considered most important (Table 4). Pre-calibration, structural 
lesions were considered most important in 53% of patients by radiologists compared 
to 23% of patients by rheumatologists. Post-calibration, structural lesions were 
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considered most important in 72% of patients by radiologists versus 53% of patients 
by rheumatologists.  
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DISCUSSION 
Our systematic and controlled evaluation of lesions visible on MRI in patients with 
early SpA has demonstrated several findings of clinical relevance to the diagnostic 
assessment of SpA by MRI. First, structural lesions such as erosion and fat infiltration 
are observed relatively frequently in early SpA even in patients with duration of symp-
toms of only 2 years. Second, information on structural lesions evident on T1w se-
quences contributes substantially to diagnostic utility and comparably to BME on the 
STIR sequence. Third, rheumatologists rely primarily on the diagnostic information 
provided by the STIR sequence and appear to be less familiar with the contribution of 
T1w abnormalities, such as erosions, which radiologists consider important to the di-
agnosis of SpA by MRI. Fourth, rheumatologist training directed specifically at detec-
tion of MRI lesions on T1w scans improves diagnostic utility of MRI.  
Since first reports in the early 1990s on the use of MRI to detect sacroiliitis 
(13), MRI has gained widespread acceptance as the most sensitive imaging modality 
for diagnostic evaluation of patients with suspected early axial SpA. Most prior studies 
on the diagnostic utility of MRI in early SpA patients (1-5) have focused on acute sac-
roiliitis lesions found on fat-suppressed or contrast-enhanced T1w sequences. A 
study of 68 patients with recent-onset IBP showed structural SIJ lesions as defined by 
erosion (irregularly delineated joint space on T1w sequence), sclerosis (low signal 
intensity on T1w, STIR and T2 fast spin echo sequences, without gadolinium en-
hancement) or ankylosis (disappearance of the joint space in all sequences) in 16% 
of the patients as opposed to inflammation in 32% (14). The concordance rate be-
tween 2 calibrated readers for structural lesions and for inflammation was 0.85 and 
0.82, respectively. Fat infiltration was not addressed in this report. However, com-
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pared to our work, the structural lesions were assessed globally for the entire right 
and left SIJ and there was no control group. In an evaluation of 41 early SpA patients, 
erosions were observed in 80%, sclerosis in 71%, and fat deposition in 63% of the 
patients, respectively, with an interobserver agreement between 2 senior radiologists 
of 71-84% for detection of these structural lesions (15). This study was based on a 
quadrantic approach separating the cartilaginous and ligamentous portion of the SIJ 
but there was no control group. In our study, erosions were observed in 50% of 27 
preradiographic IBP patients with a mean symptom duration of 29 months. This find-
ing indicates that structural damage of the SIJ which is not detectable by radiography 
is detectable by MRI and may start very early in the disease course.  
Formulating a single standardized definition for a reliable assessment of ero-
sions by MRI is complex. A similar definition of erosion has recently been published 
that also included non-enhanced T1FS and gradient echo sequences delineating the 
joint space from subchondral bone (16). These “cartilage sequences” may offer ad-
vantages and they require further studies regarding their contribution to diagnostic 
utility in SpA. Erosions detected in 11.9% of healthy controls in our study may be ex-
plained by these technical conditions or they may represent physiological variants. 
The smaller the structural lesions meeting the definition of erosion, the more difficult 
is the differentiation from physiologic variants, e.g. the insertion of ligaments, and this 
may contribute to their detection in controls. The erosion definition for SIJ should be 
validated further, according to the principles suggested by OMERACT, also investi-
gating whether a definition requiring 2 planes would be useful.  
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Prior to specific calibration for detection of structural lesions, rheumatologists 
based their diagnostic conclusion for both AS and preradiographic IBP more 
frequently on the STIR images alone than radiologists (34% versus 8%) and de-
emphasized the contribution of abnormalities on the T1w sequence, which the 
radiologists considered important to the diagnosis of SpA by MRI. This difference was 
associated with a greater recognition of the importance of erosions on T1w images by 
the radiologists compared to rheumatologists (41% versus 9%). This may be due to 
the fact that the principle focus of study of MRI for SpA in the rheumatological 
literature has been acute lesions as recognized on STIR sequences. For example, 
several methods have been developed and validated to score the degree of sacroiliac 
joint and spinal inflammation based on the assessment of BME on STIR sequences 
(17, 18). Recent interventional studies in SpA describing pivotal trials of anti-TNF 
agents have focused almost entirely on their impact on acute lesions (19, 20). In 
particular, diagnostic studies of the SIJ using MRI have focused primarily on acute 
lesions with assessment of structural lesions being exploratory in nature and not 
preceded by development of lesion definitions that facilitate standardization and 
comparability across studies. The crucial importance of this preliminary step has been 
advocated in a recent report by ASAS that described the spectrum of abnormalities 
observed in the SIJ on MRI (6). This group of experts achieved consensus on a 
definition for BME in the SIJ which then led to the formulation of a proposal for a 
positive MRI indicative of SpA based on the detection of BME. Our data driven 
approach has shown not only that structural lesions are frequent, they may occur in 
13-18% of patients with early SpA in the absence of BME, and training focused on 
their recognition can improve diagnostic utility of MRI.  
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The online recording module was designed to first capture the reader’s 
diagnosis according to a global assessment of the MRI. It is possible that diagnostic 
ascertainment may have been different if the more detailed recording of acute and 
structural lesions had been conducted first. However, this approach would lack 
external validity because clinical practice is based on global evaluation of STIR and 
T1w scans. Subsequent questions in the data entry module were aimed at 
understanding what formed the basis for the reader’s decision to score the MRI as 
indicative of SpA or not. The two senior musculoskeletal radiologists participating in 
our study both have longstanding experience in assessing MRI scans of patients with 
SpA and it was therefore instructive that their diagnostic ascertainment was so 
markedly dependent on assessment of T1w images and structural lesions. However, 
it is also likely that their emphasis on structural MR lesions of the SIJ may not be 
representative of the wider spectrum of radiologists who evaluate MRI scans for SpA. 
Nevertheless, MRI is increasingly recognized as the preferred imaging modality for 
making a diagnosis of early SpA; it will be essential for both specialties to develop 
their diagnostic skills in interpreting MRI of the SIJ. Our data shows that training 
courses will need to focus on the recognition of structural as well as acute lesions.  
A limitation of our study design is that our data do not allow us to determine 
whether the enhanced diagnostic utility after training was simply due to improved 
overall interpretation of the MRI scans as opposed to improved recognition of 
structural lesions per se.  
In conclusion, this systematic, standardized, and controlled evaluation of T1w 
and STIR sequences demonstrates that structural abnormalities occur frequently in 
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the SIJ of patients with early SpA, they may occur in the absence of BME, and they 
contribute substantially to the diagnostic utility of MRI in early SpA. Rheumatologist 
training directed at detection of structural lesions, and especially erosions, on T1w 
scans improves diagnostic utility of MRI. Further study in larger populations of pa-
tients with early SpA using this study design is necessary to clarify the diagnostic 
value of structural lesions on MRI. But it is already clear that further educational inter-
ventions should be aimed at achieving a much greater understanding of the informa-
tion provided by the T1w scan.  
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TABLES 
Table 1 
Frequency of SpA patients and controls with specific MRI abnormalities as assessed 
by 6 readers.  
Table 2 
Relative contribution of T1-weighted versus STIR sequence MRI (numbers and per-
centage) and relative contribution of acute versus structural MRI lesions (numbers 
and percentage) in those patients diagnosed with SpA by MRI.  
Table 3 
Comparison of diagnostic utility of MRI for SpA before and after training/calibration of 
readers to recognize structural lesions on T1-weighted MRI.  
Post-calibration MRI reads were undertaken on a subgroup of 30 AS patients and 34 
controls (26 patients with non-specific back pain, 8 healthy volunteers).  
Table 4 
Relative contribution of T1-weighted versus STIR sequence MRI (numbers and per-
centage) and relative contribution of acute versus structural MRI lesions (numbers 
and percentage) to the diagnosis of SpA by MRI before and after training/calibration 
of readers to recognize structural lesions on T1-weighted MRI.  
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FIGURE LEGENDS 
Figure 1. Comparison of SIJ MRI lesions on T1-weighted and on STIR sequence 
(corresponding slices of the same patient).  
Figure 1A. T1-weighted image. Erosion at the sacral side of the right SIJ (arrow). 
The marrow around this erosion demonstrates fat infiltration but there is signal loss 
(arrow) compared to normal sacral marrow (meeting the definition of erosion). The 
upper iliac part of the right SIJ shows an erosion at threshold of definition (striped 
arrow) with loss of adjacent marrow signal compared to normal iliac marrow. The left 
SIJ displays pseudo-widening of joint space due to definite erosion in the left iliac 
bone (arrowheads) showing loss of adjacent marrow signal as compared to normal 
iliac marrow. HLA B27 positive female AS patient aged 34 years with a symptom 
duration of 8 years.  
Figure 1B. STIR image. In contrast to advanced structural lesions on the T1w image, 
the corresponding STIR sequence only shows a faint BME lesion in the lower iliac 
part of the right SIJ (arrow). Areas demonstrating faint increase in STIR signal may 
create diagnostic uncertainty in routine practice as in this example of minimal 
increase in STIR signal in the right ilium. On the basis of the STIR sequence alone 
one could not confidently confirm a diagnosis of SpA by MRI. The T1-weighted 
sequence demonstrates erosions and sclerosis and illustrates how much the T1-
weighted image can be diagnostically useful when confronted with a doubtful BME 
lesion.  
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Table 1. Frequency of SpA patients and controls with specific MRI abnormalities as assessed by 6 readers. 
______________________________________________________________________________________________________________________________________________ 
Group   Any SL  ER  FI  ANK  BME  SL+/  SL-/  SL-/  SL+/ 
Reader             BME-  BME+  BME-  BME+ 
________________________________________________________________________________________________________________________________________________________________ 
75 AS patients 
Rad1   75 (100%) 71 (95%)  64 (85%)  17 (23%)  59 (79%)  16 (21%)  0 (0%)  0 (0%)  59 (79%) 
Rad2   74 (99%)  62 (83%)  65 (87%)  24 (32%)  64 (85%)  11 (15%)  1 (1%)  0 (0%)  63 (84%) 
Rheum1   70 (93%)  42 (56%)  65 (87%)  11 (15%)  64 (85%)  11 (15%)  5 (7%)  0 (0%)  59 (79%) 
Rheum2   74 (99%)  62 (83%)  65 (87%)  13 (17%)  67 (89%)  7 (9%)  0 (0%)  1 (1%)  67 (89%) 
Rheum3*   74 (99%)  60 (80%)  67 (89%)  27 (36%)  59 (79%)  16 (21%)  1 (1%)  0 (0%)  58 (77%) 
Rheum4*   75 (100%) 65 (87%)  67 (89%)  14 (19%)  54 (72%)  21 (28%)  0 (0%)  0 (0%)  54 (72%) 
Mean all 6 readers  73.7 (98.2%) 60.3 (80.4%) 65.5 (87.3%) 17.7 (23.6%) 61.2 (81.6%) 13.7 (18.2%) 1.2 (1.6%) 0.2 (0.2%) 60.0 (80.0%) 
Mean 2 radiologists  74.5 (99.3%) 66.5 (88.7%) 64.5 (86.0%) 20.5 (27.3%) 61.5 (82.0%) 13.5 (18.0%) 0.5 (0.7%) 0 (0%)  61.0 (81.3%) 
Mean 4 rheumatologists 73.3 (97.7%) 57.3 (76.3%) 66.0 (88.0%) 16.3 (21.7%) 61.0 (81.3%) 13.8 (18.3%) 1.5 (2.0%) 0.3 (0.3%) 59.5 (79.3%) 
27 IBP patients 
Rad1   21 (78%)  20 (74%)  10 (37%)  1 (4%)  16 (59%)  6 (22%)  1 (4%)  5 (19%)  15 (56%) 
Rad2   16 (59%)  14 (52%)  7 (26%)  0 (0%)  19 (70%)  3 (11%)  6 (22%)  5 (19%)  13 (48%) 
Rheum1   11 (41%)  8 (30%)  9 (33%)  0 (0%)  18 (67%)  1 (4%)  8 (30%)  8 (30%)  10 (37%) 
Rheum2   17 (63%)  13 (48%)  12 (44%)  0 (0%)  21 (78%)  3 (11%)  7 (26%)  3 (11%)  14 (52%) 
Rheum3*   17 (63%)  10 (37%)  10 (37%)  0 (0%)  19 (70%)  3 (11%)  5 (19%)  5 (19%)  14 (52%) 
Rheum4*   21 (78%)  16 (59%)  13 (48%)  3 (11%)  19 (70%)  5 (19%)  3 (11%)  3 (11%)  16 (59%) 
Mean all 6 readers  17.2 (63.6%) 13.5 (50.0%) 10.2 (37.7%) 0.7 (2.5%) 18.7 (69.1%) 3.5 (13.0%) 5.0 (18.5%) 4.8 (17.9%) 13.7 (50.6%) 
Mean 2 radiologists  18.5 (68.5%) 17.0 (63.0%) 8.5 (31.5%) 0.5 (1.9%) 17.5 (64.8%) 4.5 (16.7%) 3.5 (13.0%) 5.0 (18.5%) 14.0 (51.9%) 
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Mean 4 rheumatologists 16.5 (61.1%) 11.8 (43.5%) 11.0 (40.7%) 0.8 (2.8%) 19.3 (71.3%) 3.0 (11.1%) 5.8 (21.3%) 4.8 (17.6%) 13.5 (50.0%) 
26 NSBP controls 
Rad1   9 (35%)  6 (23%)  5 (19%)  1 (4%)  3 (12%)  6 (23%)  0 (0%)  17 (65%)  3 (12%) 
Rad2   4 (15%)  3 (12%)  2 (8%)  0 (0%)  7 (27%)  2 (8%)  5 (19%)  17 (65%)  2 (8%) 
Rheum1   7 (27%)  0 (0%)  7 (27%)  0 (0%)  6 (23%)  4 (15%)  3 (12%)  16 (62%)  3 (12%) 
Rheum2   8 (31%)  2 (8%)  7 (27%)  0 (0%)  12 (46%)  3 (12%)  7 (27%)  11 (42%)  5 (19%) 
Rheum3*   5 (19%)  3 (12%)  2 (8%)  1 (4%)  3 (12%)  3 (12%)  1 (4%)  20 (77%)  2 (8%) 
Rheum4*   10 (38%)  7 (27%)  6 (23%)  1 (4%)  3 (12%)  8 (31%)  1 (4%)  15 (58%)  2 (8%) 
Mean all 6 readers  7.2 (27.6%) 3.5 (13.5%) 4.8 (18.6%) 0.5 (1.9%) 5.7 (21.8%) 4.3 (16.7%) 2.8 (10.9%) 16.0 (61.5%) 2.8 (10.9%) 
Mean 2 radiologists  6.5 (25.0%) 4.5 (17.3%) 3.5 (13.5%) 0.5 (1.9%) 5.0 (19.2%) 4.0 (15.4%) 2.5 (9.6%) 17.0 (65.4%) 2.5 (9.6%) 
Mean 4 rheumatologists 7.5 (28.8%) 3.0 (11.5%) 5.5 (21.2%) 0.5 (1.9%) 6.0 (23.1%) 4.5 (17.3%) 3.0 (11.5%) 15.5 (59.6%) 3.0 (11.5%) 
59 Healthy controls 
Rad1   20 (34%)  13 (22%)  9 (15%)  0 (0%)  7 (12%)  16 (27%)  3 (5%)  36 (61%)  4 (7%) 
Rad2   9 (15%)  5 (8%)  6 (10%)  0 (0%)  11 (19%)  5 (8%)  7 (12%)  43 (73%)  4 (7%) 
Rheum1   8 (14%)  1 (2%)  7 (12%)  0 (0%)  14 (24%)  3 (5%)  9 (15%)  42 (71%)  5 (8%) 
Rheum2   25 (42%)  7 (12%)  19 (32%)  0 (0%)  19 (32%)  15 (25%)  9 (15%)  25 (42%)  10 (17%) 
Rheum3*   13 (22%)  3 (5%)  10 (17%)  0 (0%)  4 (7%)  12 (20%)  3 (5%)  43 (73%)  1 (2%) 
Rheum4*   19 (32%)  13 (22%)  11 (19%)  0 (0%)  8 (14%)  13 (22%)  2 (3%)  38 (64%)  6 (10%) 
Mean all 6 readers  15.7 (26.6%) 7.0 (11.9%) 10.3 (17.5%) 0 (0%)  10.5 (17.8%) 10.7 (18.1%) 5.5 (9.3%) 37.8 (64.1%) 5.0 (8.5%) 
Mean 2 radiologists  14.5 (24.6%) 9.0 (15.3%) 7.5 (12.7%) 0 (0%)  9.0 (15.3%) 10.5 (17.8%) 5.0 (8.5%) 39.5 (66.9%) 4.0 (6.8%) 
Mean 4 rheumatologists 16.3 (27.5%) 6.0 (10.2%) 11.8 (19.9%) 0 (0%)  11.3 (19.1%) 10.8 (18.2%) 5.8 (9.7%) 37.0 (62.7%) 5.5 (9.3%) 
______________________________________________________________________________________________________________________________________________ 
SpA:   Spondyloarthritis 
SL:   Structural lesion 
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Any SL:   Any structural lesion: Erosion and/or fat infiltration and/or ankylosis 
ER:   Erosion 
FI:   Fat infiltration 
ANK:   Ankylosis 
BME:   Bone marrow edema 
AS:   Ankylosing spondylitis 
IBP:   Inflammatory back pain 
NSBP:   Non-specific back pain 
Rad:   Radiologist 
Rheum:   Rheumatologist 
*   Less experienced reader 
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Table 2. Relative contribution of T1-weighted versus STIR sequence MRI (numbers and percentage) and relative contribution of acute versus structural MRI lesions (numbers and percentage) in 
those patients diagnosed with SpA by MRI. 
______________________________________________________________________________________________________________________________________________ 
Group  Number of patients   MRI sequence considered most important    MRI lesion considered most important 
Reader  diagnosed as SpA  STIR  T1  Both STIR and T1  BME  ER  FI  ANK  NA 
________________________________________________________________________________________________________________________________________________________________ 
Combined SpA patient group (AS and IBP patients, n=102) 
Rad1  87   4 (5%)  38 (44%)  45 (52%)   17 (20%)  52 (60%)  3 (3%)  14 (16%)  1 (1%) 
Rad2  80   9 (11%)  9 (11%)  62 (78%)   42 (53%)  16 (20%)  11 (14%)  11 (14%)  0 (0%) 
Rheum1  78   38 (49%)  22 (28%)  18 (23%)   Not done 
Rheum2  86   17 (20%)  2 (2%)  67 (78%)   63 (73%)  7 (8%)  4 (5%)  12 (14%)  0 (0%) 
Rheum3*  76   38 (50%)  15 (20%)  23 (30%)   55 (72%)  9 (12%)  0 (0%)  12 (16%)  0 (0%) 
Rheum4*  92   20 (22%)  15 (16%)  57 (62%)   65 (71%)  6 (7%)  8 (9%)  12 (13%)  1 (1%) 
Mean     21.0 (25.3%) 16.8 (20.2%) 45.3 (54.5%)1  48.4 (57.5%) 18 (21.4%) 5.2 (6.2%) 12.2 (14.5%) 0.4 (0.5%)2 
 
AS patients (n=75) 
Rad1  74   1 (1%)  36 (49%)  37 (50%)   8 (11%)  49 (66%)  3 (4%)  14 (19%)  0 (0%) 
Rad2  66   3 (5%)  9 (14%)  54 (82%)   29 (44%)  16 (24%)  10 (15%)  11 (17%)  0 (0%) 
Rheum1  64   26 (41%)  21 (33%)  17 (27%)   Not done 
Rheum2  72   8 (11%)  2 (3%)  62 (86%)   50 (69%)  6 (8%)  4 (6%)  12 (17%)  0 (0%) 
Rheum3*  62   26 (42%)  14 (23%)  22 (35%)   42 (68%)  8 (13%)  0 (0%)  12 (19%)  0 (0%) 
Rheum4*  71   9 (13%)  14 (20%)  48 (68%)   47 (66%)  6 (8%)  6 (8%)  12 (17%)  0 (0%) 
Mean     12.2 (17.8%) 16 (23.5%) 40 (58.7%)1  35.2 (51.0%) 17 (24.6%) 4.6 (6.7%) 12.2 (17.7%) 0 (0%)2 
 
IBP patients (n=27) 
Rad1  13   3 (23%)  2 (15%)  8 (62%)   9 (69%)  3 (23%)  0 (0%)  0 (0%)  1 (8%) 
Rad2  14   6 (43%)  0 (0%)  8 (57%)   13 (93%)  0 (0%)  1 (7%)  0 (0%)  0 (0%) 
Rheum1  14   12 (86%)  1 (7%)  1 (7%)   Not done 
Rheum2  14   9 (64%)  0 (0%)  5 (36%)   13 (93%)  1 (7%)  0 (0%)  0 (0%)  0 (0%) 
Rheum3*  14   12 (86%)  1 (7%)  1 (7%)   13 (93%)  1 (7%)  0 (0%)  0 (0%)  0 (0%) 
Rheum4*  21   11 (52%)  1 (5%)  9 (43%)   18 (86%)  0 (0%)  2 (10%)  0 (0%)  1 (5%) 
Mean     8.8 (58.9%) 0.8 (5.6%) 5.3 (35.6%)1  13.2 (86.8%) 1 (6.6%)  0.6 (3.9%) 0 (0%)  0.4 (2.6%)2 
 
________________________________________________________________________________________________________________________________________________________________________ 
 
SpA:  Spondyloarthritis 
BME:  Bone marrow edema 
ER:  Erosion 
FI:  Fat infiltration 
ANK:  Ankylosis 
AS:  Ankylosing spondylitis 
IBP:  Inflammatory back pain 
NA:  Not applicable (no lesion type predominant) 
Rad:  Radiologist 
Rheum:  Rheumatologist 
Page 32 of 39
John Wiley & Sons, Inc.
Arthritis Care & Research
*  Less experienced reader 
1
  Mean 6 readers 
2
  Mean 5 readers 
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Table 3. Comparison of diagnostic utility of MRI for SpA before and after training/calibration of readers to recognize structural lesions on T1-weighted MRI.  
Post-calibration MRI reads were undertaken on a subgroup of 30 AS patients and 34 controls (26 patients with non-specific back pain, 8 healthy volunteers). 
______________________________________________________________________________________________________________________________________________ 
Reader      Pre-Calibration         Post-Calibration 
   Sensitivity  Specificity  LR+ LR-   Sensitivity  Specificity  LR+ LR- 
________________________________________________________________________________________________________________________________________________________________ 
Radiologists 
Rad1   0.97 (29/30)  0.97 (33/34)  32.9 0.03   0.97 (29/30)  1.0 (34/34)  NC 0.03 
Rad2   0.90 (27/30)  1.0 (34/34)  NC 0.10   0.97 (29/30)  0.97 (33/34)  32.9 0.03 
Rheumatologists 
Rheum1   0.97 (29/30)  0.94 (32/34)  16.4 0.04   0.97 (29/30)  0.88 (30/34)  8.2 0.04 
Rheum2   1.0 (30/30)  0.91 (31/34)  11.3 NC   1.0 (30/30)  0.97 (33/34)  34.0 NC 
Rheum3*   0.77 (23/30)  1.0 (34/34)  NC 0.23   0.97 (29/30)  0.94 (32/34)  16.4 0.04 
Rheum4*   0.93 (28/30)  0.79 (27/34)  4.5 0.08   1.0 (30/30)  0.97 (33/34)  34.0 NC 
 
Mean all 6 readers  0.92 (0.77-1.0)  0.94 (0.79-1.0)  14.5 0.08   0.98 (0.97-1.0)  0.96 (0.88-1.0)  22.2 0.02 
All 6 readers concordantly 0.67 (20/30)  0.76 (26/34)  2.8 0.44   0.90 (27/30)  0.82 (28/34)  5.1 0.12 
______________________________________________________________________________________________________________________________________________ 
SpA:  Spondyloarthritis 
AS:  Ankylosing spondylitis 
LR+:  Positive likelihood ratio 
LR-:  Negative likelihood ratio 
NC:  Not calculable (sensitivity or specificity 1.0) 
Rad:  Radiologist 
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Rheum:  Rheumatologist 
*  Less experienced reader 
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Table 4. Relative contribution of T1-weighted versus STIR sequence MRI (numbers and percentage) and relative contribution of acute versus structural MRI lesions (numbers and percentage) to 
the diagnosis of SpA by MRI before and after training/calibration of readers to recognize structural lesions on T1-weighted MRI. 
______________________________________________________________________________________________________________________________________________ 
Reader  MRI sequence considered most important       MRI lesion considered most important 
 STIR T1 Both  STIR T1 Both   BME ER FI ANK NA  BME ER FI ANK NA 
 Pre-Calibration   Post-Calibration    Pre-Calibration     Post-Calibration 
________________________________________________________________________________________________________________________________________________________________ 
Rad1 1 (3%) 10 (33%) 19 (63%)  1 (3%) 13 (43%) 16 (53%)   8 (27%) 18 (60%) 1 (3%) 3 (10%) 0 (0%)  6 (20%) 19 (63%) 0 (0%) 3 (10%) 2 (7%) 
Rad2 2 (7%) 2 (7%) 26 (87%)  1 (3%) 1 (3%) 28 (93%)   18 (60%) 5 (17%) 3 (10%) 2 (7%) 2 (7%)  8 (27%) 17 (57%) 0 (0%) 4 (13%) 1 (3%) 
Rheum1 14 (47%) 7 (23%) 9 (30%)  9 (30%) 9 (30%) 12 (40%)   Not done 
Rheum2 3 (10%) 0 (0%) 27 (90%)  3 (10%) 0 (0%) 27 (90%)   23 (77%) 2 (7%) 3 (10%) 2 (7%) 0 (0%)  20 (67%) 7 (23%) 1 (3%) 2 (7%) 0 (0%) 
Rheum3* 15 (50%) 3 (10%) 12 (40%)  5 (17%) 3 (10%) 22 (73%)   23 (77%) 2 (7%) 0 (0%) 2 (7%) 3 (10%)  18 (60%) 9 (30%) 0 (0%) 2 (7%) 1 (3%) 
Rheum4* 5 (17%) 3 (10%) 22 (73%)  1 (3%) 6 (20%) 23 (77%)   23 (77%) 2 (7%) 2 (7%) 3 (10%) 0 (0%)  3 (10%) 23 (77%) 0 (0%) 4 (13%) 0 (0%) 
Radiologists 
 3 (5%) 12 (20%) 45 (75%)  2 (3%) 14 (23%) 44 (73%)   26 (43%) 23 (38%) 4 (7%) 5 (8%) 2 (3%)  14 (23%) 36 (60%) 0 (0%) 7 (12%) 3 (5%) 
Rheumatologists 
 37 (31%) 13 (11%) 70 (58%)  18 (15%) 18 (15%) 84 (70%)1   69 (77%) 6 (7%) 5 (6%) 7 (8%) 3 (3%)  41 (46%) 39 (43%) 1 (1%) 8 (9%) 1 (1%)2 
All readers 
 40 (22%) 25 (14%) 115 (64%) 20 (11%) 32 (18%) 128 (71%)3  95 (63%) 29 (19%) 9 (6%) 12 (8%) 5 (3%)  55 (37%) 75 (50%) 1 (1%) 15 (10%) 4 (3%)4 
______________________________________________________________________________________________________________________________________________ 
SpA:  Spondyloarthritis 
BME:  Bone marrow edema 
ER:  Erosion 
FI:  Fat infiltration 
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ANK:  Ankylosis 
NA:  Not applicable (no lesion type predominant) 
Rad:  Radiologist 
Rheum:  Rheumatologist 
*  Less experienced reader 
1
  4 rheumatologists 
2
  3 rheumatologists 
3
  6 readers 
4
  5 readers 
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Figure 1. Comparison of SIJ MRI lesions on T1-weighted and on STIR sequence (corresponding 
slices of the same patient). 
Figure 1A. T1-weighted image. 
Erosion at the sacral side of the right SIJ (arrow). The marrow around this erosion demonstrates fat 
infiltration but there is signal loss (arrow) compared to normal sacral marrow (meeting the 
definition of erosion). The upper iliac part of the right SIJ shows an erosion at threshold of definition 
(striped arrow) with loss of adjacent marrow signal compared to normal iliac marrow. The left SIJ 
displays pseudo-widening of joint space due to definite erosion in the left iliac bone (arrowheads) 
showing loss of adjacent marrow signal as compared to normal iliac marrow. HLA B27 positive 
female AS patient aged 34 years with a symptom duration of 8 years.  
139x85mm (300 x 300 DPI)  
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Figure 1B. STIR image. 
In contrast to advanced structural lesions on the T1w image, the corresponding STIR sequence only 
shows a faint BME lesion in the lower iliac part of the right SIJ (arrow). Areas demonstrating faint 
increase in STIR signal may create diagnostic uncertainty in routine practice as in this example of 
minimal increase in STIR signal in the right ilium. On the basis of the STIR sequence alone one 
could not confidently confirm a diagnosis of SpA by MRI. The T1-weighted sequence demonstrates 
erosions and sclerosis and illustrates how much the T1-weighted image can be diagnostically useful 
when confronted with a doubtful BME lesion.  
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